Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with a qualifying comorbidity. Residents of Central East Austin, Texas can access licensed Semaglutide prescriptions through telehealth — no in-person clinic visit required under Texas Occupations Code §111.001. Board-certified physicians review patient health assessments online and issue prescriptions within 24–48 hours. Compounded Semaglutide from an FDA-registered 503B outsourcing pharmacy ships overnight directly to your Austin address. Monthly cost: $199–$379 — vs. $1,247 for brand-name Ozempic or Wegovy. All prescribing physicians serving Central East Austin patients are licensed in Texas and regulated by the Texas Medical Board. Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Serving Austin ZIP codes: 78701, 78702, 78703, 78704, 78705.
Local clinics serving Central East Austin: Texas Weight Loss - South Austin, Medica Aesthetics and Bluebonnet Weight Loss. Many patients compare these in-person options against licensed Semaglutide telehealth — prescribed online, shipped to the door.
Tirzepatide seen from Central East Austin, without the jargon. Sold as Mounjaro for diabetes and Zepbound for weight loss, tirzepatide stands out for its unique dual-hormone mechanism.
Some compounding pharmacies bill per vial, others per full program - comparing the 'all-in' cost avoids surprises at refill time. The monthly cost depends mostly on the format you choose: the brand-name version without insurance is by far the most expensive, while compounded telehealth formulas cut the bill sharply.
In this state, Texas Occupations Code §111.001; the reference body is Texas Medical Board. Local landmark: Texas Weight Loss - South Austin (6104 S 1st St Ste 102, Austin, TX 78745), rated 4.8/5 across 237 reviews. On the cost side, expect about $250-600/month compounded via telehealth; about $1,000-1,400/month brand-name without insurance. depending on the format (brand vs compounded). Associated brands include Mounjaro, Zepbound.
Coverage varies by plan and indication; many patients without coverage opt for a compounded formula at a fixed monthly cost.
In the SURMOUNT head-to-head trials, tirzepatide produced greater average weight loss, likely thanks to its dual GIP + GLP-1 action. Response is individual and should be assessed by a physician.
Yes: both are tirzepatide. Mounjaro is dosed/labeled for type 2 diabetes, Zepbound for weight management.
Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Licensed in Texas. All prescriptions issued under Texas Occupations Code §111.001 and supervised by Texas Medical Board.